Lars P. Bechmann

4.7k total citations · 1 hit paper
79 papers, 3.2k citations indexed

About

Lars P. Bechmann is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Lars P. Bechmann has authored 79 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 36 papers in Hepatology and 20 papers in Surgery. Recurrent topics in Lars P. Bechmann's work include Liver Disease Diagnosis and Treatment (58 papers), Liver Disease and Transplantation (23 papers) and Drug-Induced Hepatotoxicity and Protection (11 papers). Lars P. Bechmann is often cited by papers focused on Liver Disease Diagnosis and Treatment (58 papers), Liver Disease and Transplantation (23 papers) and Drug-Induced Hepatotoxicity and Protection (11 papers). Lars P. Bechmann collaborates with scholars based in Germany, United States and Netherlands. Lars P. Bechmann's co-authors include Ali Canbay, Guido Gerken, Rebekka A. Hannivoort, Michael Trauner, Gökhan S. Hotamışlıgil, Jan‐Peter Sowa, Christoph Jochum, Martin Schlattjan, Robert K. Gieseler and Svenja Sydor and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Lars P. Bechmann

77 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The interaction of hepatic lipid and glucose metabolism in liver diseases

2011 762 citations Lars P. Bechmann, Rebekka A. Hannivoort et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by Lars P. Bechmann

Since Specialization

Citations

This map shows the geographic impact of Lars P. Bechmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars P. Bechmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars P. Bechmann more than expected).

Fields of papers citing papers by Lars P. Bechmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars P. Bechmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars P. Bechmann. The network helps show where Lars P. Bechmann may publish in the future.

Co-authorship network of co-authors of Lars P. Bechmann

This figure shows the co-authorship network connecting the top 25 collaborators of Lars P. Bechmann. A scholar is included among the top collaborators of Lars P. Bechmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars P. Bechmann. Lars P. Bechmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	S2k-Leitlinie Klinische Ernährung in der Hepatologie 2024 ·Aktuelle Ernährungsmedizin ·Mathias Plauth, Lars P. Bechmann, (unknown), Felix Gundling, Ludwig Kramer, Andreas E. Kremer, Monika Rau, Andreá Schneider, Frank Tacke, Ingo van Thiel	1
2	Mitochondrial DNA methylation in metabolic associated fatty liver disease 2023 ·Frontiers in Nutrition ·(unknown), Fabián Cortés-Mancera, Janette Heegsma, (unknown), Bart van de Sluis, Svenja Sydor, Lars P. Bechmann, (unknown), Peter De Rijk, Tim De Pooter, Wim Vanden Berghe, İkbal Agah İnce, Klaas Nico Faber, Marianne G. Rots	14
3	Long-term exposure to air pollution and prevalent nonalcoholic fatty liver disease 2023 ·Environmental Epidemiology ·(unknown), (unknown), Sarah Lucht, Julia Kälsch, Tom Luedde, Raimund Erbel, Andreas Stang, Börge Schmidt, Scott L. Friedman, Ali Canbay, Lars P. Bechmann, Barbara Hoffmann	14
4	GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients 2021 ·Pharmaceuticals ·Clemens Schotten, (unknown), Jan‐Peter Sowa, Paul Manka, Lars P. Bechmann, (unknown), C. Marquardt, Marc Wichert, Hidenori Toyoda, Christian M. Lange, Ali Canbay, Philip J. Johnson, Heiner Wedemeyer, Jan Best	34
5	Intestinal Epithelial Cell-Derived Extracellular Vesicles Modulate Hepatic Injury via the Gut-Liver Axis During Acute Alcohol Injury 2020 ·Frontiers in Pharmacology ·(unknown), L. Ortega Morán, Peng Jin, Beatriz Salinas, (unknown), Svenja Sydor, Ramiro Vilchez‐Vargas, (unknown), Fengjie Hao, Kang Zheng, (unknown), Laura Moreno, Ángel Cogolludo, Manuel Gómez del Moral, Lars P. Bechmann, Eduardo Martı́nez-Naves, Javier Vaquero, Rafael Bañares, Yulia A. Nevzorova, Francisco Javier Cubero	25
6	Metaproteomics of fecal samples of Crohn's disease and Ulcerative Colitis 2019 ·Journal of Proteomics ·(unknown), Kay Schallert, Ramiro Vilchez‐Vargas, Dirk Benndorf, Sebastian Püttker, Svenja Sydor, Christian Schulz, Lars P. Bechmann, Ali Canbay, Benjamin Heidrich, Udo Reichl, Alexander Link, Robert Heyer	49
7	Protective role of c‐Jun N‐terminal kinase‐2 (JNK2) in ibuprofen‐induced acute liver injury 2018 ·The Journal of Pathology ·Miguel Eugenio Zoubek, (unknown), Svenja Sydor, Leonard J. Nelson, Lars P. Bechmann, M. Isabel Lucena, Raúl J. Andrade, Aalt Bast, Ger H. Koek, Christian Trautwein, Francisco Javier Cubero	8
8	The Presence and Severity of Nonalcoholic Steatohepatitis Is Associated with Specific Changes in Circulating Bile Acids 2018 ·Annals of Hepatology ·(unknown), Lars P. Bechmann, Ali Canbay	19
9	Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury 2015 ·Gastroenterology ·Francisco Javier Cubero, Miguel Eugenio Zoubek, Wei Hu, Peng Jin, (unknown), Yulia A. Nevzorova, (unknown), Lars P. Bechmann, Mark V. Boekschoten, Michael Müller, Christian Preisinger, Nikolaus Gaßler, Ali Canbay, Tom Luedde, Roger J. Davis, Christian Liedtke, Christian Trautwein	70
10	Higher Thyroid-Stimulating Hormone, Triiodothyronine and Thyroxine Values Are Associated with Better Outcome in Acute Liver Failure 2015 ·PLoS ONE ·Olympia E. Anastasiou, Svenja Sydor, Jan‐Peter Sowa, Paul Manka, Antonios Katsounas, Wing‐Kin Syn, Dagmar Führer, Robert K. Gieseler, Lars P. Bechmann, Guido Gerken, Lars C. Moeller, Ali Canbay	14
11	Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently 2014 ·Gut ·A Beilfuss, Jan‐Peter Sowa, Svenja Sydor, Mechthild Beste, Lars P. Bechmann, Martin Schlattjan, Wing‐Kin Syn, Inga Wedemeyer, Zoltán Máthé, Christoph Jochum, Guido Gerken, Robert K. Gieseler, Ali Canbay	120
12	Adiponectin attenuates osteolysis in aseptic loosening of total hip replacements 2013 ·Acta Biomaterialia ·Stefan Landgraeber, (unknown), Martin Schlattjan, Lars P. Bechmann, Martin Tötsch, Florian Grabellus, Gero Hilken, Markus Jäger, Ali Canbay	15
13	Novel Algorithm for Non-Invasive Assessment of Fibrosis in NAFLD 2013 ·PLoS ONE ·Jan‐Peter Sowa, Dominik Heider, Lars P. Bechmann, Guido Gerken, Daniel Hoffmann, Ali Canbay	56
14	94 KRÜPPEL-LIKE FACTOR 6 REGULATES PPAR ALPHA SIGNALING IN STEATOHEPATITIS VIA REPRESSION OF MIR-10B 2011 ·Journal of Hepatology ·Lars P. Bechmann, Diana Vetter, Rebekka A. Hannivoort, (unknown), Maria Isabel Fiel, Gillian Patman, Úrsula Muñoz, (unknown), Peri Kocabayoglu, Helen L. Reeves, (unknown)	1
15	Magnetic endoscopic imaging saves abdominal compression and patient pain in routine colonoscopies 2011 ·Journal of Digestive Diseases ·Alexander Dechêne, Christoph Jochum, Lars P. Bechmann, (unknown), Guido Gerken, Ali Canbay, T Zöpf	8
16	Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury 2010 ·Journal of Hepatology ·Lars P. Bechmann, Christoph Jochum, Peri Kocabayoglu, Jan‐Peter Sowa, (unknown), Robert K. Gieseler, Fuat H. Saner, Andreas Paul, Christian Trautwein, Guido Gerken, Ali Canbay	119
17	Acute Liver Failure in a Metropolitan Area in Germany: a Retrospective Study (2002 – 2008) 2009 ·Zeitschrift für Gastroenterologie ·Ali Canbay, (unknown), Lars P. Bechmann, (unknown), Robert K. Gieseler, Zafer Yüksel, P Lütkes, Fuat H. Saner, Antoni Paul, (unknown)	53
18	Apoptotic Markers Indicate Nonalcoholic Steatohepatitis in Polycystic Ovary Syndrome 2009 ·The Journal of Clinical Endocrinology & Metabolism ·Susanne Tan, Lars P. Bechmann, Sven Benson, Tiina Dietz, (unknown), Susanne Hahn, Onno E. Janßen, Harald Lahner, Guido Gerken, Klaus Mann, Ali Canbay	44
19	Successful photodynamic therapy for biliary papillomatosis: A case report 2008 ·World Journal of Gastroenterology ·Lars P. Bechmann, Philip Hilgard, Andrea Frilling, Brigitte Schumacher, Hideo A. Baba, Guido Gerken, Thomas Zoepf	14
20	Crohn’s Disease-Induced Non-Alcoholic Fatty Liver Disease (NAFLD) Sensitizes for Severe Acute Hepatitis B Infection and Liver Failure 2006 ·Zeitschrift für Gastroenterologie ·Ali Canbay, Lars P. Bechmann, Jan Best, Christoph Jochum, (unknown), Guido Gerken	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact